https://knews.kathimerini.com.cy/en/news/widely-used-anti-covid-drug-linked-to-virus-mutations
An anti-Covid drug widely used across the world may have caused mutations in the virus, researchers said on Monday, but there was no evidence that the changes had led to more dangerous variants....
https://knews.kathimerini.com.cy/en/news/molnupiravir-administered-to-almost-one-thousand-covid-patients-in-cyprus
Molnupiravir, the antiviral medication for COVID, has been administered to almost one thousand patients in Cyprus, according to Deputy Head of pharmaceutical services Elena Panagiotopoulou....
https://knews.kathimerini.com.cy/en/news/msd-pill-how-many-cypriots-received-it-and-how-many-were-hospitalized
More and more drugs are being included in doctors' inventories in order to deal with the pandemic. At the moment, at the European level, eight are available - pills and monoclonal antibodies - which Cyprus has taken care to secure....
https://knews.kathimerini.com.cy/en/news/antiviral-pill-by-pfizer-expected-in-cyprus-by-mid-february
Plaxovid, the Pfizer antiviral pill against COVID-19 has been approved by EMA and is expected in Cyprus by mid-February,...
https://knews.kathimerini.com.cy/en/news/infected-patients-in-cyprus-go-on-new-antiviral-pill
Over a dozen high-risk patients have been prescribed an oral antiviral drug in the Republic of Cyprus this week, but officials have declined to provide data saying the numbers were too small to form a big picture...
https://knews.kathimerini.com.cy/en/news/molnupiravir-now-available-in-cyprus-as-of-today
MSD's oral antiviral medicine Molnupiravir/Lagevrio, will be available only with a prescription from Monday, 17 January, according to the Ministry of Health in Cyprus....
https://knews.kathimerini.com.cy/en/news/israel-to-offer-fourth-covid-vaccine-shot-to-over-60s-medical-staff
Prime Minister Naftali Bennett said on Sunday that Israel would offer a fourth dose of COVID-19 vaccine to people over 60 and to medical staff as it faces a surge in Omicron variant infections....
https://knews.kathimerini.com.cy/en/news/fda-approves-two-at-home-covid-treatments
The U.S. Food and Drug Administration on Thursday authorized Merck & Co's (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar treatment from Pfizer Inc (PFE.N) for high-risk patients above the age of 12....
https://knews.kathimerini.com.cy/en/news/covid-antiviral-pill-to-arrive-in-cyprus-mid-december
The first antiviral pill for COVID-19 is expected in Cyprus in the second half of December, according to deputy head of pharmaceutical services Elena Panagiotopoulou. The pill will be used for mild to moderate cases of the disease....
https://knews.kathimerini.com.cy/en/news/covid-pill-may-be-approved-in-as-little-as-a-few-weeks
Merck has applied for an emergency use authorization for a COVID pill that treats mild-to moderate patients of COVID-19, according to a report from Reuters....
https://knews.kathimerini.com.cy/en/news/coronavirus-the-antibiotic-that-may-mark-the-end-of-the-pandemic
The final clinical trials of the drug with molnupiravir raise significant hopes for antibiotic treatment for those who have already contracted coronavirus,...
